Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 521,565
  • Shares Outstanding, K 71,940
  • Annual Sales, $ 19,390 K
  • Annual Income, $ -71,660 K
  • 36-Month Beta 3.10
  • Price/Sales 28.94
  • Price/Cash Flow 0.00
  • Price/Book 4.45

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.25 +70.59%
on 05/01/17
8.60 -15.70%
on 05/16/17
+2.25 (+45.00%)
since 04/26/17
3-Month
3.85 +88.31%
on 03/22/17
8.60 -15.70%
on 05/16/17
+3.25 (+81.25%)
since 02/24/17
52-Week
2.65 +173.58%
on 12/08/16
8.60 -15.70%
on 05/16/17
+0.71 (+10.86%)
since 05/26/16

Most Recent Stories

More News
Shares of SGMO Up 17.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Sangamo Biosciences (NASDAQ:SGMO) on May 11th, 2017 at $6.65. In approximately 2 weeks, Sangamo Biosciences has returned 17.29% as of today's recent price of $7.80....

SGMO : 7.25 (-7.05%)
Will Sangamo Therapeutics (SGMO) Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Sangamo Therapeutics Inc (SGMO).

SGMO : 7.25 (-7.05%)
Sangamo's (SGMO) Hemophilia A Drug Gets Fast-Track Status

Sangamo Therapeutics, Inc. (SGMO) announced that the FDA has granted fast track designation to pipeline candidate, SB-525.

SGMO : 7.25 (-7.05%)
VVUS : 1.13 (+0.89%)
SHPG : 177.18 (-4.13%)
PFE : 32.14 (-0.06%)
Biotech Stock Roundup: Biogen Inks Deal to Boost Pipeline, Sangamo Soars on Pfizer Deal

Quite a few deals were announced this week including by companies like Biogen (BIIB).

SGMO : 7.25 (-7.05%)
AKBA : 13.43 (-3.03%)
VRTX : 119.92 (+1.11%)
IONS : 46.38 (+0.06%)
REGN : 455.17 (-0.12%)
ALXN : 97.70 (-0.81%)
BIIB : 250.80 (-0.86%)
Is the Options Market Predicting a Spike in Sangamo Therapeutics (SGMO) Stock?

Investors in Sangamo Therapeuticsm, Inc. (SGMO) need to pay close attention to the stock based on moves in the options market lately.

SGMO : 7.25 (-7.05%)
Sangamo Therapeutics Presents Recent Developments from Research and Clinical Programs at Annual Meeting of the American Society of Gene & Cell Therapy

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) today highlighted data from research and clinical-stage programs presented over the past week at the 20th Annual Meeting of the American Society of Gene & Cell...

SGMO : 7.25 (-7.05%)
How These Biotech Stocks are Faring? -- Seattle Genetics, Sangamo Therapeutics, Vertex Pharma, and VIVUS

On Friday, May 12, 2017, the Dow Jones Industrial Average and the S&P 500 edged 0.11% and 0.15% lower, respectively at the closing bell, while the NASDAQ Composite stayed bullish, finishing marginally...

SGMO : 7.25 (-7.05%)
VVUS : 1.13 (+0.89%)
VRTX : 119.92 (+1.11%)
SGEN : 65.57 (-0.68%)
Today's Research Reports on Stocks to Watch: Conatus Pharmaceuticals and Sangamo Therapeutics

NEW YORK, NY / ACCESSWIRE / May 12, 2017 / Conatus shares took a mean dive after the company disclosed a public offering of its stock at $5.50 per share. Sangamo Therapeutics on the other hand climbed...

SGMO : 7.25 (-7.05%)
CNAT : 5.17 (-1.71%)
After Yesterday's Rally of 47.70% Shares Could Potentially Pullback

Sangamo Biosciences (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $6.05 to a high of $6.80. Yesterday, the shares gained 47.7%, which took the trading range above the 3-day high...

SGMO : 7.25 (-7.05%)
Sangamo Therapeutics Announces First Quarter 2017 Conference Call And Webcast

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, announced today that the company will release its first quarter 2017 financial results after the market closes on Wednesday,...

SGMO : 7.25 (-7.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sangamo BioSciences, Inc. is a leader in the development of noveltranscription factors for the regulation of gene expression. Transcriptionfactors are proteins that turn genes on or off by recognizing specific DNAsequences. The Universal Gene Recognition technology platform enables theengineering of...

See More

Support & Resistance

2nd Resistance Point 8.12
1st Resistance Point 7.68
Last Price 7.25
1st Support Level 7.03
2nd Support Level 6.82

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.